For the Quarter Ending March 2026
Ofloxacin Prices in North America
- In United States, the Ofloxacin Price Index rose quarter-over-quarter in Q1 2026, driven by elevated production costs.
- The Ofloxacin Production Cost Trend increased in March 2026 as the 3.3% CPI rise elevated logistics expenses.
- Elevated producer prices rose 4.0% in March 2026, directly increasing Ofloxacin API synthesis and formulation costs.
- The Manufacturing Index expanded and industrial production grew 0.7% in March 2026, limiting excess Ofloxacin API supply.
- Retail sales increased 4.0% and unemployment reached 4.3% in March 2026, supporting steady prescription fulfillment for infections.
- Consumer confidence reached a 91.8 index in March 2026, supporting out-of-pocket healthcare spending and the Ofloxacin Demand Outlook.
- Overall demand for systemic fluoroquinolones weakened in Q1 2026 as prescribing patterns shifted following regulatory safety warnings.
- The Ofloxacin Price Forecast remained elevated in Q1 2026 as API availability constraints restricted overall generic production.
Why did the price of Ofloxacin change in March 2026 in North America?
- Pharmacy-level inventories of sterile ophthalmic solutions tightened significantly in Q1 2026 due to regional stockouts.
- National supply of sterile formulations tightened in Q1 2026 due to manufacturing disruptions and quality issues.
- Healthcare drug shortages tightened in Q1 2026, restricting generic production and elevating the Ofloxacin Price Index.
Ofloxacin Prices in APAC
- In China, the Ofloxacin Price Index rose quarter-over-quarter in Q1 2026, driven by surging upstream feedstock costs.
- The Ofloxacin Production Cost Trend increased in March 2026 as factory-gate prices rose, reflected by a 0.5% PPI.
- The Ofloxacin Demand Outlook remained stable in March 2026, supported by a mild 1.0% CPI increase ensuring purchasing power.
- Industrial production grew by 5.7% in March 2026, ensuring high availability of upstream chemical precursors for Ofloxacin synthesis.
- Retail sales grew 1.7% and unemployment reached 5.4% in March 2026, driving substitution toward cost-effective generic Ofloxacin treatments.
- The Manufacturing Index expanded in March 2026, while consumer confidence hit 91.6 in February 2026, impacting non-essential veterinary applications.
- Benzene and naphtha feedstock costs surged in Q1 2026 following severe supply chain disruptions and escalating crude oil valuations.
- The Ofloxacin Price Forecast pointed upward in March 2026 as light distillate inventories plummeted across major storage hubs.
Why did the price of Ofloxacin change in March 2026 in APAC?
- Benzene feedstock costs surged in March 2026 due to escalating global upstream crude oil valuations.
- Domestic availability of key aromatic feedstocks tightened in March 2026 following unplanned regional plant downtime.
- Domestic demand for pharmaceutical intermediates expanded in Q1 2026, driven by stronger generic drug output.
Ofloxacin Prices in Europe
- In Germany, the Ofloxacin Price Index fell quarter-over-quarter in Q1 2026, driven by declining upstream energy costs.
- The Ofloxacin Production Cost Trend faced upward pressure from a 2.7% CPI inflation rate in March 2026.
- However, producer prices declined by 0.2% in March 2026, easing upstream costs for Ofloxacin API manufacturing.
- The Manufacturing Index expanded in March 2026, supporting steady formulation and packaging schedules for Ofloxacin products.
- Industrial production remained stagnant in February 2026, reflecting flat baseline activity for Ofloxacin supply chains.
- Retail sales grew 0.7% and unemployment stayed at 4.2% in February 2026, sustaining the Ofloxacin Demand Outlook.
- Negative consumer confidence at -24.7 in March 2026 reduced discretionary spending, softening veterinary Ofloxacin demand.
- Natural gas and electricity prices dropped significantly in February 2026, lowering energy-intensive Ofloxacin API synthesis costs.
- The Ofloxacin Price Forecast indicated a downward trajectory during January-March 2026 due to abolished gas levies.
Why did the price of Ofloxacin change in March 2026 in Europe?
- Electricity and natural gas prices dropped significantly in February 2026, reducing Ofloxacin API manufacturing costs.
- Producer prices declined by 0.2% in March 2026, easing upstream cost pressures for Ofloxacin precursors.
- The abolition of the gas storage levy in January 2026 improved Ofloxacin supply cost structures.
For the Quarter Ending December 2025
Ofloxacin Prices in APAC
- In China, the Ofloxacin Price Index fell quarter-over-quarter in Q4 2025, driven by decreasing production costs and subdued consumer demand.
- Ofloxacin production costs declined in December 2025, as producer prices decreased by 1.9% year-over-year.
- Weak consumer demand was evident with CPI at 0.8% and retail sales up 0.9% year-over-year in December 2025.
- Demand for Ofloxacin API was supported by robust pharmaceutical market growth in 2025 and expanding industrial output.
- The manufacturing index expanded in December 2025, and industrial production increased by 5.2% year-over-year.
- Elevated inventory levels for basic chemicals were projected in 2025 due to global overcapacity.
- China's medicine exports steadily increased during the first eleven months of 2025, supporting trade flows.
- Unemployment stood at 5.1% in December 2025, contributing to cautious consumer sentiment.
Why did the price of Ofloxacin change in December 2025 in APAC?
- Producer prices declined by 1.9% year-over-year in December 2025, lowering Ofloxacin manufacturing costs.
- Subdued consumer demand, with CPI at 0.8% and retail sales up 0.9% year-over-year in December 2025.
- Intensified global overcapacity in key chemical building blocks in 2025 pressured Ofloxacin prices downward.
Ofloxacin Prices in North America
- In United States, the Ofloxacin Price Index rose in Q4 2025, driven by elevated production costs and robust health spending.
- Ofloxacin production costs increased during Q4 2025, influenced by a 3.0% rise in PPI year-over-year in November 2025.
- Elevated natural gas spot prices in Q4 2025 and increased electricity costs in November 2025 raised Ofloxacin manufacturing expenses.
- Ofloxacin demand outlook remained strong in 2025, supported by robust national health spending growth.
- A 4.4% unemployment rate in December 2025 bolstered patient access to Ofloxacin and healthcare services.
- Industrial production increased 2.0% year-over-year in December 2025, supporting the broader Ofloxacin supply chain.
- Consumer confidence at 89.1 in December 2025 indicated moderate optimism, indirectly supporting stable Ofloxacin demand.
- U.S. chemical feedstock export capacity expanded in Q4 2025, influencing broader chemical market dynamics.
Why did the price of Ofloxacin change in December 2025 in North America?
- Ofloxacin production costs increased from a 2.7% CPI rise in December 2025 and elevated natural gas prices.
- Robust national health spending in 2025 and a 4.4% unemployment rate in December 2025 supported Ofloxacin demand.
- Increased electricity costs in November 2025 and a 3.0% PPI rise in November 2025 pressured Ofloxacin prices.
Ofloxacin Prices in Europe
- In Germany, the Ofloxacin Price Index declined in Q4 2025, due to intensified competitive pressure in October 2025.
- Ofloxacin production costs rose from high raw material costs in October 2025 and strengthened electricity prices in December 2025.
- The Manufacturing Index was contracting in December 2025, indicating a slowdown in overall economic activity.
- Ofloxacin demand outlook was challenged by a 6.2% unemployment rate and low consumer confidence (-17.5 index) in December 2025.
- Weak domestic and export orders in October 2025 impacted German chemical industry trade flows.
- German chemical industry capacity utilization remained low in 2025, as order backlogs plummeted in October 2025.
- European natural gas prices faced upward pressure into winter 2025, increasing Ofloxacin energy feedstock costs.
- The Producer Price Index (PPI) declined 2.5% year-over-year in December 2025, easing some input cost pressures.
Why did the price of Ofloxacin change in December 2025 in Europe?
- Intensified competitive pressure from international markets in October 2025 prompted chemical companies to lower prices.
- Weak domestic and export orders in October 2025 and a contracting Manufacturing Index in December 2025 reduced demand.
- Despite a 1.8% CPI increase in December 2025, a 2.5% PPI decline in December 2025 eased producer costs.
For the Quarter Ending September 2025
Ofloxacin Prices in North America
- In United States, Ofloxacin Price Index rose in Q3 2025, driven by rising costs and strong pharmaceutical market sentiment.
- Ofloxacin production costs increased in Q3 2025, influenced by 2.6% PPI rise by August 2025.
- Rising input prices and strengthened industrial electricity in September 2025 elevated Ofloxacin expenses.
- Ofloxacin demand was positive, supported by strengthened pharmaceutical market sentiment and surging drug approvals in Q3 2025.
- Robust consumer spending, retail sales up 5.42% in September 2025, supported patient access and Ofloxacin demand.
- Low unemployment rate of 4.3% in September 2025 contributed to stable healthcare spending and Ofloxacin demand.
- US manufacturing inventories tightened in Q3 2025, and chemical output slipped, impacting Ofloxacin supply.
- Henry Hub natural gas prices inched up from August to September 2025, increasing Ofloxacin energy costs.
- Declining consumer confidence to 94.2 in September 2025 may temper future Ofloxacin demand.
Why did the price of Ofloxacin change in September 2025 in North America?
- Ofloxacin production costs rose from 2.6% PPI increase by August 2025.
- Strong pharmaceutical sentiment and 5.42% retail sales growth in September 2025 boosted demand.
- Tightened US manufacturing inventories and decelerated output growth in Q3 2025 pressured prices.
Ofloxacin Prices in APAC
- In China, Ofloxacin Price Index fell in Q3 2025, influenced by falling factory-gate prices and subdued consumer confidence.
- Ofloxacin production costs increased in Q3 2025 due to rising natural gas prices and higher demand for chemical intermediates.
- Ofloxacin demand outlook was mixed; retail sales grew 3.0% in September 2025, but consumer confidence was low.
- China's industrial production expanded 6.5% year-on-year in September 2025, supporting stable supply of Ofloxacin inputs.
- The Manufacturing Index was contracting in September 2025, reflecting a slowdown in the broader chemical industry.
- Deflationary pressures, with CPI falling 0.3% year-on-year in September 2025, impacted consumer purchasing power.
- Pharmaceutical goods exports from China inched down August-September 2025, while imports saw a more significant decline.
- Ofloxacin price forecast suggests continued pressure from weak domestic demand and persistent chemical oversupply.
Why did the price of Ofloxacin change in September 2025 in APAC?
- Producer prices fell 2.3% in September 2025, pressuring Ofloxacin selling prices downward.
- Consumer confidence at 89.6 in September 2025 reflected pessimism, moderating Ofloxacin demand.
- Rising natural gas prices in Q3 2025 contributed to increased production costs for Ofloxacin intermediates.
Ofloxacin Prices in Europe
- In Germany, the Ofloxacin Price Index rose quarter-over-quarter in Q3 2025, driven by increased production costs.
- Ofloxacin production costs increased in Q3 2025, influenced by elevated energy prices for German businesses.
- Demand for Ofloxacin faced headwinds in Q3 2025 as Germany's Manufacturing Index was contracting in September 2025.
- A low 3.9% unemployment rate in September 2025 supported Ofloxacin demand by bolstering consumer purchasing power.
- Overall industrial output declined by -1.0% year-over-year in September 2025, indicating a weaker economic environment.
- Consumer confidence remained significantly negative at -23.6 in September 2025, impacting discretionary healthcare spending.
- German chemical exports faced weak demand in Q3 2025, while European sales stagnated, affecting Ofloxacin trade.
- The pharmaceutical market in Germany experienced moderate growth in 2025, driven by an aging population and chronic diseases.
Why did the price of Ofloxacin change in September 2025 in Europe?
- Elevated energy costs in Q3 2025 increased Ofloxacin production expenses in Germany.
- German pharmaceutical industry faced increased price and cost pressure during Q3 2025.
- Producer prices declined by -1.7% in September 2025, moderating Ofloxacin input cost increases.
